ARIAD PHARMACEUTICALS INC Business Finance Contracts & Agreements
45 Contracts & Agreements
- Assignment Agreements (1 contract)
- Credit Agreements (7)
- Exchange Agreements (1)
- Guarantee Agreements (1)
- Indenture Agreements (1)
- Loan Agreements (1)
- Note Agreements (5)
- Registration Rights Agreements (1)
- Release Agreements (1)
- Security Agreements (4)
- Share Agreements (1)
- Stock Agreements (13)
- Subscription Agreements (1)
- Underwriting Agreements (5)
- Warrant Agreements (2)
- CALL OPTION AND WARRANT TERMINATION AGREEMENT (Filed With SEC on January 10, 2017)
- PARTIAL RELEASE OF SECURITY INTEREST (Filed With SEC on August 8, 2016)
- SHARE PURCHASEAGREEMENT byand among INCYTEEUROPE S.à r.l., ARIADPHARMACEUTICALS (CAYMAN) L.P., ARIADPHARMACEUTICALS, INC. (AS GUARANTOR), and INCYTE CORPORATION(AS GUARANTOR) (Filed With SEC on August 8, 2016)
- SECURITY AGREEMENT (Filed With SEC on November 6, 2015)
- REVENUE INTEREST ASSIGNMENT AGREEMENT Dated as of July 28, 2015 between ARIADPHARMACEUTICALS, INC. and PDL BIOPHARMA, INC. Portions of this Exhibit, indicated by the mark [***],... (Filed With SEC on November 6, 2015)
- ARIAD PHARMACEUTICALS, INC. 3.625% Convertible Senior Notes due 2019 Purchase Agreement (Filed With SEC on June 17, 2014)
- ARIAD PHARMACEUTICALS, INC., and WELLS FARGO BANK, NATIONALASSOCIATION, as Trustee INDENTURE Dated as of June 17,2014 3.625% Convertible Senior Notes due 2019 TABLE OF CONTENTS (Filed With SEC on June 17, 2014)
- SECTION 382 RIGHTS AGREEMENT dated as of October 31, 2013 between ARIAD PHARMACEUTICALS,INC. and COMPUTERSHARETRUST COMPANY, N.A., as Rights Agent Table of Contents (Filed With SEC on November 1, 2013)
- ARIAD PHARMACEUTICALS, INC. 15,307,000 Shares of Common Stock, par value $0.001 per share Underwriting Agreement (Filed With SEC on January 24, 2013)
- FORM OF RESTRICTED STOCK GRANT CERTIFICATE (Filed With SEC on February 29, 2012)
- FORM OF RESTRICTED STOCK UNIT CERTIFICATE (Filed With SEC on February 29, 2012)
- FORM OF STOCK GRANT CERTIFICATE For Directors (Filed With SEC on February 29, 2012)
- FORM OF STOCK OPTION CERTIFICATE (Filed With SEC on February 29, 2012)
- AMENDMENT NO. 7 TO CREDIT AGREEMENT (Filed With SEC on February 29, 2012)
- ASSIGNMENT AND ASSUMPTION AGREEMENT (CAMBRIDGE, MASSACHUSETTS) (Filed With SEC on February 29, 2012)
- ARIAD PHARMACEUTICALS, INC. 21,500,000 Shares of Common Stock, par value $0.001 per share Underwriting Agreement (Filed With SEC on December 15, 2011)
- AMENDMENT NO. 6 TO CREDIT AGREEMENT (Filed With SEC on January 12, 2011)
- WAIVER AND AMENDMENT NO. 5 TO CREDIT AGREEMENT (Filed With SEC on March 16, 2010)
- WAIVERAND AMENDMENT NO. 4 TO CREDIT AGREEMENT (Filed With SEC on August 10, 2009)
- Ex-10.3 Form of Subscription Agreement between ARIAD Pharmaceuticals, Inc. and each of the purchasers (Filed With SEC on February 20, 2009)
- Ex-10.2 Form of Warrant to purchase shares of ARIAD Pharmaceuticals, Inc. common stock (Filed With SEC on February 20, 2009)
- Ex-10.4 Guarantee, dated September 11, 2008 - Laurie A. Allen, Esq (Filed With SEC on September 17, 2008)
- Ex-10.1 Common Stock Purchase Agreement (Filed With SEC on February 15, 2007)
- EX-1.1 Underwriting Agreement, dated October 19, 2006 (Filed With SEC on October 20, 2006)
- FORM OF RESTRICTED STOCK UNIT CERTIFICATE (Filed With SEC on August 8, 2006)
- FORM OF STOCK GRANT CERTIFICATE (Filed With SEC on August 8, 2006)
- FORM OF STOCK OPTION CERTIFICATE (Filed With SEC on August 8, 2006)
- ARIAD PHARMACEUTICALS, INC. 2001 STOCK PLAN AS AMENDED AND RESTATED (EFFECTIVE AS OF SEPTEMBER 27, 2005) (Filed With SEC on November 9, 2005)
- 7,500,000 Shares ARIAD PHARMACEUTICALS, INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on August 5, 2005)
- SECOND AMENDED AND RESTATED TERM NOTE (Filed With SEC on February 18, 2005)
- AMENDMENT NO. 2 TO CREDIT AGREEMENT (Filed With SEC on February 18, 2005)
- EX-1.1 UNDERWRITING AGREEMENT DATED MARCH 23, 2004 (Filed With SEC on March 24, 2004)
- EX-10.59 STOCK ISSUANCE AGREEMENT (Filed With SEC on March 2, 2004)
- EX-10.58 FIRST AMENDMENT AND RESTATED TERM NOTE (Filed With SEC on March 2, 2004)
- EX-10.57 AMENDMENT NO. 1 TO CREDIT AGREEMENT (Filed With SEC on March 2, 2004)
- EX-10.8 NON-QUALIFIED STOCK OPTION AGREEMENT (Filed With SEC on November 4, 2003)
- EX-10.1 FORM OF STOCK PURCHASE AGREEMENT (Filed With SEC on October 3, 2003)
- EX-10.5 SECURITY AGREEMENT/ARIAD GENE THERAPEUTICS (Filed With SEC on May 13, 2003)
- EX-10.4 SECURITY AGREEMENT - ARIAD CORPORATION (Filed With SEC on May 13, 2003)
- EX-10.3 SECURITY AGREEMENT - ARIAD PHARMACEUTICALS (Filed With SEC on May 13, 2003)
